Physician

Candice Colleen Colby-Scott, M.D.

According to 2025 Medicare claims, Candice Colby-Scott, M.D. (NPI: 1922268119) practices otolaryngology in the Midland, MI market, with the plurality of this provider's patient population coming from Midland, MI. This provider's primary affiliated billing organization is GLB ENT PLLC (NPI: 1265259618; TIN: 995100638) and primary practice location at 48640-5488. Colby-Scott is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Colby-Scott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 2,216 HCPCS/CPT codes, and received $87,362 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 515 prescription claims across 212 beneficiaries totaling $27,213 in drug costs, led by Ciprofloxacin-Dexamethasone (Ciprofloxacin Hcl/Dexameth). Open Payments data shows 21 records totaling $696. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $12,556 and ending at $87,362. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,259 to $27,213. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	62	259	$12,556
2016	159	634	$52,330
2017	300	939	$59,487
2018	553	1,929	$130,154
2019	341	1,110	$75,213
2020	89	187	$16,784
2021	207	765	$106,398
2022	256	2,044	$112,846
2023	249	1,558	$114,081
2024	224	2,216	$87,362

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	87	$1,259
2016	97	319	$8,284
2017	103	242	$8,970
2018	211	541	$21,124
2019	167	374	$42,854
2020	60	167	$31,563
2021	155	339	$17,788
2022	217	562	$62,633
2023	282	702	$48,373
2024	212	515	$27,213

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	35	35	$145
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	90	90	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	123	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	34	45	$61
69210	Removal of impacted ear wax	67	81	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	70	907	$8,201
Prednisolone Acetate	Prednisolone Acetate	27	353	$1,420
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	624	$1,145
Ofloxacin	Ofloxacin	13	147	$547
Nortriptyline Hcl	Nortriptyline Hcl	57	2,184	$433

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$696	Cochlear Americas
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Candice Colleen Colby-Scott, M.D.?

Tedicare shows public-source Medicare data for Candice Colleen Colby-Scott, M.D. (NPI 1922268119), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Candice Colleen Colby-Scott, M.D. have ACO affiliation data?

Candice Colleen Colby-Scott, M.D. is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Candice Colleen Colby-Scott, M.D.?

Candice Colleen Colby-Scott, M.D. is linked to GLB ENT PLLC (billing NPI 1265259618) in the available physician profile data.

Does Candice Colleen Colby-Scott, M.D. have Open Payments data?

Candice Colleen Colby-Scott, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.